News Gilead strikes deal to expand HIV drug access in 120 countri... Gilead Sciences has taken a major step towards increasing global access to HIV prevention with the signing of royalty-free
Market Access SteinCares and Sandoz: Bringing high-quality healthcare prod... Recently, pharmaphorum spoke with Sebastian Katz, chief strategy officer of specialty healthcare company Stein Holding Group (SteinCares), to discuss the announcement of its licensing agree
